yeast persorption (Krause, Matheis and Wulf, 1969; Stone, 1974; Stone et al., 1973 Stone et al., , 1974 , or directly during intestinal surgery. Environmental fungi can reach the blood via indwelling catheters and i.v. needles and flourish in peri-catheteral sleeve thrombi (Anderson and Yardley, 1972) or in the endocardium, traumatized by tubes that reach the heart (Law et al., 1972; MacMillan, Law and Holder, 1972) . Intratracheal intubation can push oral Candida into the lower respiratory passages and lead to pulmonary infection, serving as the focus for endocardial invasion, as with primary pulmonary fungal pathogens (Buchbinder and Roberts, 1972) . Abortions Toala et al., 1970; Editorial, 1971) . Suppression of bacteria alone increases the growth of fungi when both are present in the endocardium.
Iatrogenic measures can suppress host defences, e.g. directly by antibiotics (Seelig, 1966a, b) , or by suppression of enteric flora as in gnotobiotic animals (Abrams and Bishop, 1965 (Lee et al., 1961; Hairston et al., 1969 Silverman, 1957) and intracellular killing capacity (Miyamoto, 1965; Cocchi and Marianelli, 1967; Coen, Gursh and Kauder, 1969) . Quie (1969) correlated white blood cell (WBC) metabolic defects of infancy and those seen in CGD. Uhr (1966) (Kirkpatrick, Rich and Bennett, 1971) . Perhaps the susceptibility of geriatric patients to fungal endocarditis might be partially attributed to impaired cellular defences, such as shown by Tillotson and Finland (1969) for pulmonary macrophages of the aged. The susceptibility of diabetics to fungal endocarditis might be an expression of such decreased phagocytic response to experimental fungal infections as has been demonstrated in alloxanized animals (Schauble and Baker 1957; Bauer, 1959, 1960; Bybee and Rogers, 1964 (Seelig, 1979b) (Karnovsky, 1962; Rogers, 1964) and the aminoglycosides that cause renal Mg wasting (Holmes, Hesling and Wilson, 1970; Bar, Wilson and Mazzaferri, 1975; Keating et al., 1977) . Both groups decrease phagocytic uptake (Munoz and Geister, 1950; Forsgren, 1974) and intracellular killing capacity (Alexander and Good, 1968) . Magnesium is necessary for WBC clumping and adherence of bacteria (Allison, Lancaster and Crosthwaite, 1963; Allison and Lancaster, 1965) and is involved in phagocytosis and mobility (Wilkins and Bangham, 1964; Brennan, Seelig and Lichtman, 1979) . Antibacterial-suppression of phagocytosis is reversible by Mg (Downey and Pisano, 1966) . Cardiac surgery patients develop hypomagnesaemia (Scheinman, Sullivan and Hyatt, 1969; Holden, Ionescu and Woller 1972; Khan, Hodge and Bassett, 1973; Holden, 1979) , possibly contributed to by the use of acid-citrate-dextrose pump-prime (Killen, Grogan and Collins, 1971 ). This might be a factor in their susceptibility to FE.
It is conceivable that antenatal and infantile magnesium deficiency might contribute to cardiac abnormalities (Seelig, , 1979a and infantile and later metabolic immunological disorders. For example, thymic abnormalities have developed in Mg-deficient rats (Bois, 1968; Alcock et al., 1973; Hass, McCreary and Laing, 1979) . Neonatally thymectomized mice are susceptible to Candida infection (Salvin, Peterson and Good, 1965) . Humoral immunological defects also develop with Mg-deficiency (Alcock and Shils, 1974; Elin, 1975; Larvor, 1979) . Whether phagocytic, T-cell and other immunological dysfunctions might be contributed to by therapeutic measures that cause Mgloss or inactivation remains to be ascertained.
Fungal pathogens in endocarditis
The most common FE pathogens are Candida spp., most commonly after cardiac surgery and complicating bacterial endocarditis therapy (Seelig et al., , 1974 Engleman et al., 1973; Rubinstein et al., 1975; Stone, 1975; Turnier et al., 1975; Utley, Mills and Roe, 1975; Premsingh et al., 1976; Gladstone et al., 1976; Watanakunakorn, 1977; Rotheram and Magovern, 1977; Arnon and Ehrlich, 1977; Eilard et al., 1978; Wain et al., 1979 Utz, 1974; Carrizosa et al., 1974; Harford, 1974; Rubinstein et al., 1975) . Histoplasma capsulatum can also cause endocarditis (Merchant et al., 1958; Hartley, Reinsberg and Sinaly, 1967) , as have the Cryptococcaceae: (1) Cryptococcus neoformans (Merchant et al., 1958; Shelburne and Carey, 1962; Stein, Harken and Dexter, 1966; Cherubin and Neu, 1971; Naveh et al., 1975) ; (2) Torulopsis sp. (Lees et al., 1971; Rubinstein et al., 1975; Utley et al., 1975; Sharpe et al., 1975; Eilard et al., 1978) ; and (3) Saccharomyces (Stein, Folkens and Hruska, 1970) . In his tabulation of cases of mucormycosis, Baker (1970) listed several with Mucor endocarditis (Torack, 1957; Gloor, L6ffler and Scholer, 1961; Suga, Hagal and Kashima, 1963 (Merchant et al., 1958) and Paecilomyces fungal endocarditis (Uys, Don and Schrire, 1963; Silver, Tuffnel and Bigelow, 1971; Haldane et al., 1974) , and Phialophora FE has also been reported (Pierach et al., 1973; Rubinstein et al., 1975) .
Experimental fungal endocarditis
Fungal endocarditis models include heart surgery in dogs (Cooper et al., 1961) , advancing peripherally inserted polyethylene i.v. tubes containing Candida to the hearts of rabbits (Freedman and Johnson, 1972) , inserting a polyethylene catheter across the aorta and injecting Candida (Sande, Bowman and Calderone, 1977) , and securing an intraventricular catheter and injecting Aspergillus (Carrizosa, Kohn and Levinson, 1975) . Most animals showed rapid clearance of fungaemia, despite progression of FE. Candida antibodies developed in all rabbits that survived at least 12 days, and rose progressively in those with persistent FE (Sande et al., 1977 (Taschdjian et al., 1971; Meister et al., 1977; Stone et al., 1974) , and even in heart valves (Calderone, Rotondo and Sande, 1978 (Maki, Goldmann and Rhame, 1973; Miller and Grogan, 1973; Goldmann and Maki, 1973) . Laminar air-flow rooms, used for total parenteral nutrition-solution preparation, can become contaminated with Candida (Bodey, 1973 Turnier et al., 1975) . The vegetations must be removed because of their impenetrability by such solutions (Rubinstein et al., 1974) . Long-term treatment and follow-up are necessary (Rubinstein et al., 1975; Premsingh et al., 1976) , preferably with monitoring of Candida precipitins or agglutinins or both (Seelig et al., 1974;  Galgiani and Stevens, 1977; Kelly Smith and Hsieh, 1978) . Dr Stevens (Borelli et al., 1979) proposed that cases be categorized as 5-or 10-year remissions rather than cures. In fact, 3 of the tabulated patients reported as cured later died of recurrences (cases 59-61). Six were well at 3 years' (or more) follow-up (cases [36] [37] [38] 41, 50, 63) , which brings the total 3 years + cures for Candida FE to 11, including early and probable cases treated promptly, usually with antifungal drugs alone (cases 3, 4, 12, 20, 31) . Four were clinically and serologically negative at follow-up at 3 years or less (cases 39, 48, 51, 62) . The absence of clinical recurrence in most is not assurance of recovery; 2 have had positive serology and are in doubt (cases 50, 63) even though one has been free of overt disease for 5 years (case 50).
Drug toxicity has often prevented completion of an adequate course of therapy. New orally-effective imidazoles, and combinations of antifungal drugs, may permit more effective and tolerable therapy to be sustained long enough for complete elimination of fungi from the heart. Fourteen of the cases in Tables 1 and 2 received combination systemic  therapy (cases 20, 31, 34, 42, [48] [49] [50] [51] [60] [61] [62] [63] Rich and Smith, 1972; Graybill et al., 1973; Stevens, 1977) .
Other means of stimulating host defences include autologous vaccines-given parenterally or orally (Beemer et al., 1976; Beemer, Kutlin and Pinto, 1977) -and chemotherapeutic stimulation of cellular immunity such as levamisole (Renoux and Renoux, 1972; Tripodi, Parks and Brugmans, 1973 
